Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms

By Fainardi E.   Castellazzi M.   Casetta I.   Cultrera R.   Vaghi L.   Granieri E.   Contini C.  

Journal of the Neurological Sciences, Vol. 217, Iss. 2, 2004-02 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite

Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis

By Dong-Si T.   Weber J.   Liu Y.   Buhmann C.   Bauer H.   Bendl C.   Schnitzler P.   Grond-Ginsbach C.   Grau A.  

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 542-547

Springer Publishing Company

Access to resources Recommend Favorite

Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response

By Wick M.  

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1325-1335

Oxford University Press

Access to resources Recommend Favorite

Oligoclonal bands in multiple sclerosis patients: worse prognosis?

By Rojas J I   Tizio S   Patrucco L   Cristiano E  

Neurological Research, Vol. 34, Iss. 9, 2012-11 ,pp. : 889-892

Maney Publishing

Access to resources Recommend Favorite

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients

By Zephir H.   de Seze J.   Duhamel A.   Debouverie M.   Hautecoeur P.   Lebrun C.   Malikova I.   Pelletier J.   Senechal O.   Vermersch P.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 73-77

Elsevier

Access to resources Recommend Favorite